Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Income Statement [Abstract]
Revenue	$ 0	$ 1,788	$ 4,288	$ 6,311
Operating expenses:
Research and development	25,745	14,946	61,451	50,676
General and administrative	8,279	7,902	25,035	22,324
Impairment of long-lived assets	0	4,838	0	4,838
Total operating expenses	34,024	27,686	86,486	77,838
Loss from operations	(34,024)	(25,898)	(82,198)	(71,527)
Other income (expense):
Change in fair value of warrant liability	(292)	75	(463)	(67)
Change in fair value of term loan	(1,534)	(1,703)	(4,525)	(4,035)
Interest income	3,169	2,107	6,354	5,240
Interest expense	(15)	(24)	(51)	(80)
Other expense	(37)	(81)	(261)	(44)
Total other income, net	1,291	374	1,054	1,014
Net loss	$ (32,733)	$ (25,524)	$ (81,144)	$ (70,513)
Net loss per common share, basic	$ (0.09)	$ (0.1)	$ (0.26)	$ (0.29)
Net loss per common share, diluted	$ (0.09)	$ (0.1)	$ (0.26)	$ (0.29)
Weighted average common shares outstanding, basic	353,309,524	267,824,045	307,175,982	244,052,057
Weighted average common shares outstanding, diluted	353,309,524	267,824,045	307,175,982	244,052,057